Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TriphroCaps Softgels is a prescription-strength renal vitamin supplement developed and marketed by Trigen Laboratory. It is specifically formulated to provide nutritional support for patients with renal impairment, including those with chronic kidney disease (CKD) or end-stage renal disease (ESRD) undergoing hemodialysis or peritoneal dialysis. The product contains a combination of water-soluble vitamins, including Vitamin C (ascorbic acid), B-complex vitamins (thiamine, riboflavin, niacinamide, pantothenic acid, pyridoxine, and cyanocobalamin), Folic Acid, and Biotin. These vitamins are essential for various metabolic processes and are frequently depleted during the dialysis process or restricted due to the dietary limitations required for managing renal failure. TriphroCaps is administered orally as a softgel to help prevent and treat vitamin deficiencies in this specific patient population.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TriphroCaps Softgels.